Nonoverlapping T and B Cell Determinants on an Hepatitis B Surface Antigen Pre-S(2) Region Synthetic Peptide

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1986 Aug 1

PMID 2425034

Citations 19

Authors

D R Milich

A McLachlan

F V Chisari

G B Thornton

Affiliations

Soon will be listed here.

Abstract

We have examined T cell recognition of a hepatitis B surface antigen (HBsAg), pre-S(2)-region synthetic peptide, p120-145, in terms of fine specificity, H-2-linked genetic influences, comparison to antibody binding, and relevance to T cell recognition of the native protein. We showed that the immune response to the synthetic peptide is regulated by H-2-linked genes, but that the pattern of H-2 restriction differed from that observed for the native anti-pre-S(2) response. Dominant and nonoverlapping T cell and B cell recognition sites were identified on the synthetic peptide p120-145. T cell recognition is focussed on the NH2-terminal sequence, and antibody (B cell) recognition is focussed on the COOH-terminal sequence. The fine specificity of T cell recognition of p120-145 was defined by a single, subtype-dependent amino acid substitution. With respect to the immunogenicity of p120-145, the synthetic peptide containing both T and B cell determinants is highly immunogenic in responder strains, whereas separate T or B cell peptide determinants are minimally immunogenic. Furthermore, the synthetic T cell recognition site can prime T cell help for antibody production to the synthetic B cell site, which is crossreactive with the native pre-S(2) region of HBsAg/p33 particles. This system provides evidence that totally synthetic T cell and B cell recognition sites can be combined to yield a functional immunogen.

Citing Articles

An apolipoprotein B100 mimotope prevents obesity in mice.

Kim H, Lee H, Choi J, Han J, Kim J, Na H Clin Sci (Lond). 2015; 130(2):105-16.

PMID: 26519425 PMC: 4673603. DOI: 10.1042/CS20150423.

Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster.

Bucher B, Francioli P, Geudelin B, Fritzell B, Lavanchy D, Frei P Eur J Clin Microbiol Infect Dis. 1994; 13(3):212-7.

PMID: 8050433 DOI: 10.1007/BF01974539.

Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus.

Graham S, Wang E, Jenkins O, Borysiewicz L J Virol. 1993; 67(3):1627-37.

PMID: 7679749 PMC: 237534. DOI: 10.1128/JVI.67.3.1627-1637.1993.

Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent.

Milich D, Peterson D, Schodel F, Jones J, Hughes J J Virol. 1995; 69(5):2776-85.

PMID: 7535865 PMC: 188971. DOI: 10.1128/JVI.69.5.2776-2785.1995.

Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.

Burkhart C, Freer G, Castro R, Adorini L, Wiesmuller K, Zinkernagel R J Virol. 1994; 68(3):1573-80.

PMID: 7508998 PMC: 236614. DOI: 10.1128/JVI.68.3.1573-1580.1994.

References

Click R, Benck L, Alter B . Immune responses in vitro. I. Culture conditions for antibody synthesis. Cell Immunol. 1972; 3(2):264-76. DOI: 10.1016/0008-8749(72)90165-7. View

Shastri N, Miller A, Sercarz E . The expressed T cell repertoire is hierarchical: the precise focus of lysozyme-specific T cell clones is dependent upon the structure of the immunogen. J Mol Cell Immunol. 1984; 1(6):369-79. View

Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P . Hepatitis B virus genes and their expression in E. coli. Nature. 1979; 282(5739):575-9. DOI: 10.1038/282575a0. View

Milich D, Chisari F . Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982; 129(1):320-5. View

Werdelin O . Chemically related antigens compete for presentation by accessory cells to T cells. J Immunol. 1982; 129(5):1883-91. View

Stibbe W, Gerlich W . Variable protein composition of hepatitis B surface antigen from different donors. Virology. 1982; 123(2):436-42. DOI: 10.1016/0042-6822(82)90275-6. View

Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K . The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res. 1983; 11(6):1747-57. PMC: 325833. DOI: 10.1093/nar/11.6.1747. View

Rock K, Benacerraf B . Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation. J Exp Med. 1983; 157(5):1618-34. PMC: 2186997. DOI: 10.1084/jem.157.5.1618. View

Pincus M, Gerewitz F, Schwartz R, Scheraga H . Correlation between the conformation of cytochrome c peptides and their stimulatory activity in a T-lymphocyte proliferation assay. Proc Natl Acad Sci U S A. 1983; 80(11):3297-300. PMC: 394028. DOI: 10.1073/pnas.80.11.3297. View

10.

Milich D, Leroux-Roels G, LOUIE R, Chisari F . Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions. J Exp Med. 1984; 159(1):41-56. PMC: 2187186. DOI: 10.1084/jem.159.1.41. View

11.

Machida A, Kishimoto S, Ohnuma H, Baba K, Ito Y, Miyamoto H . A polypeptide containing 55 amino acid residues coded by the pre-S region of hepatitis B virus deoxyribonucleic acid bears the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology. 1984; 86(5 Pt 1):910-8. View

12.

Neurath A, Kent S, Strick N . Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus. Science. 1984; 224(4647):392-5. DOI: 10.1126/science.6200931. View

13.

Heermann K, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich W . Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol. 1984; 52(2):396-402. PMC: 254539. DOI: 10.1128/JVI.52.2.396-402.1984. View

14.

Michel M, Pontisso P, Sobczak E, Malpiece Y, Streeck R, Tiollais P . Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A. 1984; 81(24):7708-12. PMC: 392221. DOI: 10.1073/pnas.81.24.7708. View

15.

Milich D, LOUIE R, Chisari F . Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions. J Immunol. 1985; 134(6):4194-202. View

16.

Milich D, Peterson D, Leroux-Roels G, Lerner R, Chisari F . Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity. J Immunol. 1985; 134(6):4203-11. View

17.

Neurath A, Kent S, Strick N, Taylor P, Stevens C . Hepatitis B virus contains pre-S gene-encoded domains. Nature. 1985; 315(6015):154-6. DOI: 10.1038/315154a0. View

18.

Milich D, Thornton G, Neurath A, Kent S, Michel M, Tiollais P . Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 1985; 228(4704):1195-9. DOI: 10.1126/science.2408336. View

19.

Watts T, Gariepy J, Schoolnik G, McConnell H . T-cell activation by peptide antigen: effect of peptide sequence and method of antigen presentation. Proc Natl Acad Sci U S A. 1985; 82(16):5480-4. PMC: 391146. DOI: 10.1073/pnas.82.16.5480. View

20.

Schwartz R, FOX B, Fraga E, Chen C, Singh B . The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency. J Immunol. 1985; 135(4):2598-608. View